Rolling back the government advantages given vaccines would level the R&D playing field and help end the drought in pharmaceutical breakthroughs.
Mistakes in novel areas of science inevitably happen, and especially in highly politicized periods where public panic can run high and governments are under the gun.
The medical-industrial-governmental complex spends more and more but has less and less to show for it.
Our bodies have changed in the last generation, making us more susceptible than we were a scant few decades ago.
Pharma giant Merck faces at least two lawsuits alleging wrongdoing over its Measles-Mumps-Rubella (MMR) vaccine — hearings made all the more explosive given the introduction of race into the mix. Continue reading Merck has some explaining to do over their MMR vaccine claims
This response, published by American Thinker, to CPI’s Vaccinating the ‘herd,’ takes issue with several of its statements, particularly in regard to risk factors for children.
Mass vaccination advocates rely on ‘herd immunity’ to make their case. But it doesn’t exist.
Because different gene sequences determine how different vaccines at different doses affect us, vaccines in the ideal should be customized to the individual.
Road tolls don’t deprive people of options, they add travel options for all, improving the quality of life.
Vaccinomics — personalized vaccines married to genomics — are no pie-in-the-sky fantasy but possibly the next big coming thing. Dr. Gregory Poland, one of the world’s most admired, most advanced thinkers in the field of vaccinology, certainly thinks so.